biguanides has been researched along with Hyperglycemia in 29 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Furthermore metformin seems to decrease cancer risk in diabetic patients." | 6.46 | Metformin for aging and cancer prevention. ( Anisimov, VN, 2010) |
| " Weight loss was greater in patients with lower baseline HbA1c and in patients taking concomitant biguanides." | 5.22 | Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes. ( Iwamoto, N; Nishiyama, H; Ohyama, S; Onishi, Y; Oura, T; Takeuchi, M, 2016) |
| "Furthermore metformin seems to decrease cancer risk in diabetic patients." | 2.46 | Metformin for aging and cancer prevention. ( Anisimov, VN, 2010) |
| "impaired glucose tolerance (IGT) and NIDDM, conveys a great risk of macrovascular disease." | 2.39 | Oral antidiabetic drugs: an overview. ( Melander, A, 1996) |
| "Biguanides were found to be conducive to normalization of thrombelastogram values, not elevating the blood serum content of lactic acid even after exercise test." | 1.28 | [Effect of biguanides on the indicators of thrombelastography and the level of lactic acid in diabetes mellitus]. ( Babenko, AIu; Blagosklonnaia, IaV; Krasil'nikova, EI; Zaĭed, N, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 5 (17.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gorina, EI | 1 |
| Popova, TN | 1 |
| Shulgin, KK | 1 |
| Popov, SS | 1 |
| Panchenko, LF | 1 |
| Safonova, OA | 1 |
| Onishi, Y | 1 |
| Oura, T | 1 |
| Nishiyama, H | 1 |
| Ohyama, S | 1 |
| Takeuchi, M | 1 |
| Iwamoto, N | 1 |
| Anisimov, VN | 1 |
| Chaudhuri, A | 1 |
| Dandona, P | 1 |
| Manolopoulos, VG | 1 |
| Ragia, G | 1 |
| Tavridou, A | 1 |
| Kotake, H | 1 |
| Jellinger, PS | 1 |
| Peden, N | 1 |
| Newton, RW | 1 |
| Feely, J | 1 |
| Scheen, AJ | 1 |
| Lefèbvre, PJ | 1 |
| Wolffenbuttel, BH | 1 |
| van Haeften, TW | 1 |
| Melander, A | 1 |
| Skyler, JS | 1 |
| Haffner, SM | 1 |
| Charbonnel, B | 1 |
| Hügl, SR | 1 |
| Palitzsch, KD | 1 |
| Ratner, RE | 1 |
| Jerums, G | 1 |
| Blagosklonnaia, IaV | 1 |
| Krasil'nikova, EI | 1 |
| Zaĭed, N | 1 |
| Babenko, AIu | 1 |
| Marble, A | 1 |
| Hermann, LS | 1 |
| Loiseau, G | 1 |
| Millischer, R | 1 |
| Berthe, G | 1 |
| Donadieu, AM | 1 |
| Lohier, P | 1 |
| Marquet, JP | 1 |
| Wechsler, B | 1 |
| Tschudi-Steiner, I | 1 |
| Lestradet, H | 1 |
| Berger, W | 1 |
| Lorch, E | 1 |
| Fratino, P | 3 |
| Maggi, G | 3 |
| Rodari, T | 3 |
13 reviews available for biguanides and Hyperglycemia
| Article | Year |
|---|---|
Metformin for aging and cancer prevention.
Topics: Aging; Animals; Antineoplastic Agents; Biguanides; Caloric Restriction; Humans; Hyperglycemia; Hypog | 2010 |
Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Topics: Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dipeptidyl-Pe | 2011 |
Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective.
Topics: Administration, Oral; Animals; Biguanides; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 2 | 2011 |
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism | 2002 |
Metabolic consequences of hyperglycemia and insulin resistance.
Topics: Biguanides; Cannabinoid Receptor Modulators; Cardiovascular Diseases; Dyslipidemias; Fatty Acids, No | 2007 |
Antihyperglycaemic agents. Drug interactions of clinical importance.
Topics: Administration, Oral; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Drug Interactions; Drug | 1995 |
Prevention of complications in non-insulin-dependent diabetes mellitus (NIDDM).
Topics: Acarbose; Aldehyde Reductase; Biguanides; Diabetes Mellitus, Type 2; Glucose; Guanidines; Humans; Hy | 1995 |
Oral antidiabetic drugs: an overview.
Topics: Biguanides; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Glucose Int | 1996 |
The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.
Topics: Acarbose; Adult; Aged; Aged, 80 and over; Arteriosclerosis; Biguanides; Blood Glucose; Cardiovascula | 1998 |
Controlling postprandial hyperglycemia.
Topics: Biguanides; Blood Glucose; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemi | 2001 |
Pharmacology of antihyperglycemic drugs.
Topics: Administration, Oral; Biguanides; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Hyperg | 1972 |
Biguanides and lactate metabolism: a review.
Topics: Acidosis; Animals; Biguanides; Blood Glucose; Carbon Radioisotopes; Diabetes Mellitus; Gluconeogenes | 1973 |
[Adverse effects of important long-term-therapeutics].
Topics: Acidosis; Animals; Antidepressive Agents; Antitubercular Agents; Biguanides; Central Nervous System; | 1970 |
1 trial available for biguanides and Hyperglycemia
| Article | Year |
|---|---|
Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes.
Topics: Aged; Biguanides; Body Mass Index; Combined Modality Therapy; Diabetes Mellitus, Type 2; Double-Blin | 2016 |
15 other studies available for biguanides and Hyperglycemia
| Article | Year |
|---|---|
[The effect of biguanide derivatives on oxidative stress in rats with hyperglycemia].
Topics: Animals; Biguanides; Hyperglycemia; Liver; Male; Myocardium; Oxidative Stress; Rats | 2018 |
Oral hypoglycaemic agents.
Topics: Biguanides; Diabetes Mellitus; Diet, Diabetic; Humans; Hyperglycemia; Hypoglycemic Agents; Sulfonylu | 1983 |
Targeted glycemic control in type 2 diabetes.
Topics: Aged; Algorithms; Anti-Obesity Agents; Biguanides; Blood Glucose; Blood Glucose Self-Monitoring; Chr | 1998 |
[New classification and diagnostic criteria of diabetes. Interview with Prof. B. Charbonnel].
Topics: Biguanides; Diabetes Mellitus; Enzyme Inhibitors; Glucosidases; Humans; Hyperglycemia; Hypoglycemic | 1999 |
[What is new about diabetes mellitus, type 2?].
Topics: Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hyperinsulinism; Kidney Failure, Chron | 1999 |
The biguanides: action and clinical indications.
Topics: Biguanides; Diabetes Mellitus; Humans; Hyperglycemia; Metformin; Phenformin | 1976 |
[Effect of biguanides on the indicators of thrombelastography and the level of lactic acid in diabetes mellitus].
Topics: Adolescent; Adult; Aged; Biguanides; Blood Coagulation; Diabetes Mellitus, Type 1; Diabetes Mellitus | 1990 |
[A phosphorylated biguanide: benfosformin (JAV 852). I. Hypoglycemic and antidiabetic properties].
Topics: Animals; Benzyl Compounds; Biguanides; Blood Glucose; Diabetes Mellitus, Experimental; Hyperglycemia | 1973 |
[Management of diabetes mellitus].
Topics: Adult; Aged; Biguanides; Body Weight; Diabetes Mellitus; Diet Therapy; Humans; Hyperglycemia; Insuli | 1974 |
[Is there only one type of diabetes?].
Topics: Arteriosclerosis; Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Ketoacidosis; Gluco | 1966 |
[Causes of the blood sugar decreasing effect of biguanides].
Topics: Animals; Biguanides; Blood Glucose; Depression, Chemical; Dogs; Gluconeogenesis; Humans; Hyperglycem | 1970 |
Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat.
Topics: Administration, Oral; Amino Sugars; Animals; Anti-Bacterial Agents; Biguanides; Diabetes Mellitus; G | 1971 |
[On the mechanism of action of phenethylbiguanide (PEBG). IV. Effect on adrenalin-induced hyperglycemia in normal animals].
Topics: Animals; Biguanides; Epinephrine; Hyperglycemia; Hypoglycemic Agents; Rabbits | 1967 |
[On the mechanism of action of phenethylbiguanide (PEBG). 3. Effects on glucagon-induced hyperglycemia in vivo].
Topics: Animals; Biguanides; Glucagon; Hyperglycemia; Hypoglycemic Agents; Rabbits | 1967 |
[Mechanism of action of phenethylbigunide (PEBG). V. Administration in the hyperglycemic rabbit during continous glucose perfusion].
Topics: Animals; Biguanides; Blood Glucose; Glucose; Hyperglycemia; Hypoglycemic Agents; Infusions, Parenter | 1967 |